GLP-1 drugs slash £1BN from UK grocery spend as household uptake surges

GLP-1 pen
The proportion of British households with a GLP-1 drug user increased from 6.3% in February to 8.5% in August. (Getty Images)

The rise in take-up of GLP-1 medication has created a £1 billion hole in British grocery spending.

New research has revealed that the proportion of British households with a GLP-1 drug user increased from 6.3% in February to 8.5% in August.

An estimated 2.6 million adults across Great Britain are now using weight-loss medication.

The impact of GLP-1 drugs on grocery spending has now exceeded £1 billion, up from £780 million in June, with 415 million fewer packs purchased. This equates to £389 annually being displaced from the shopping baskets of user households.

However, the findings suggest this is not solely driven by shoppers buying less. While overall spending and volumes are declining at a similar rate, changing consumer habits are creating winners and losers across different categories.

Products typically associated with impulse and indulgence purchases are experiencing the biggest declines.

Alcohol spending among users has fallen 15% more than in non-user households, while spending on crisps has dropped by 15%, highlighting a reduction in impulse purchases as consumers snack less.

By contrast, convenient, portion-controlled options are gaining popularity. Frozen ready meals have recorded a 30% increase in volume, while a more unexpected growth category is hot chocolate and malt drinks, with spending up 22% and volumes rising 16%.

While spending on treats may be declining among GLP-1 users, the figures suggest that small, convenient everyday comforts continue to hold their appeal.

Senior consultant Nishita Pattni at Worldpanel by Numerator said: “GLP-1 users are now found in as many British homes as some of Great Britain’s best-known food and drink brands, and growth is accelerating.

“In just six months, between February and August 2026, user numbers rose almost as much as they did in the whole of the previous year. For many people, a daily pill is far easier than an injection, and with the surge in male users, we only expect the appeal of these drugs to grow.”


Also read → How wide is the GLP-1 halo?

Notably, the findings also show that GLP-1 users are now present in 8.5% of British households, matching the combined proportion of households with vegetarians and pescatarians.

This is comparable to the proportion buying Corona beer (8.4%) or Kellogg’s Rice Krispies (8.6%).

Worldpanel by Numerator has been monitoring the impact of these drugs on purchasing behaviour since March 2024. Its fourth wave of research was based on a sample of 9,629 households.

Although GLP-1 pills only received recent approval from the Medicines and Healthcare products Regulatory Agency (MHRA) in June 2026, they already account for 11.2% of users, or more than one in 10.

Men are also driving growth, representing 32% of users, up from 23% in February. This equates to a near doubling of male users, with numbers rising from 440,000 in February to 830,000.

Outside the grocery sector, some of the money saved is being redirected towards health and beauty products.

GLP-1 users spent £78 million more than expected on health and beauty products during the first year after starting treatment, while 30% reported spending more on clothing and footwear.

Head of public sector and nutrition at Worldpanel by Numerator Chantel Kennaugh said: “Too often, the GLP-1 impact is framed as a story about value or volume decline, but there’s a much more interesting story sitting behind this.

“From a grocery perspective, this new audience is being more mindful about what and how they eat. The key for retailers is how to support them, without isolating them. This might be as simple as producing clear labels that highlight nutrients like high protein or ensuring ranges are available in smaller portion sizes.”

She continued: “Our estimates suggest that GLP-1 usage is set to surpass 10% of GB households in 2027. This is not a flash-in-the-pan trend, but a seismic change that requires retailers and manufacturers to re-think their strategies.”